458 related articles for article (PubMed ID: 27232760)
1. Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies.
Avery LB; Wang M; Kavosi MS; Joyce A; Kurz JC; Fan YY; Dowty ME; Zhang M; Zhang Y; Cheng A; Hua F; Jones HM; Neubert H; Polzer RJ; O'Hara DM
MAbs; 2016; 8(6):1064-78. PubMed ID: 27232760
[TBL] [Abstract][Full Text] [Related]
2. Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approach.
Betts A; Keunecke A; van Steeg TJ; van der Graaf PH; Avery LB; Jones H; Berkhout J
MAbs; 2018 Jul; 10(5):751-764. PubMed ID: 29634430
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models.
Valente D; Mauriac C; Schmidt T; Focken I; Beninga J; Mackness B; Qiu H; Vicat P; Kandira A; Radošević K; Rao S; Darbyshire J; Kabiri M
MAbs; 2020; 12(1):1829337. PubMed ID: 33079615
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Human Pharmacokinetics Profile of Monoclonal Antibody Using hFcRn Transgenic Mouse Model.
Nakamura G; Ozeki K; Takesue H; Tabo M; Hosoya KI
Biol Pharm Bull; 2021; 44(3):389-395. PubMed ID: 33642546
[TBL] [Abstract][Full Text] [Related]
5. Correlations between pharmacokinetics of IgG antibodies in primates vs. FcRn-transgenic mice reveal a rodent model with predictive capabilities.
Tam SH; McCarthy SG; Brosnan K; Goldberg KM; Scallon BJ
MAbs; 2013; 5(3):397-405. PubMed ID: 23549129
[TBL] [Abstract][Full Text] [Related]
6. Utility of immunodeficient mouse models for characterizing the preclinical pharmacokinetics of immunogenic antibody therapeutics.
Myzithras M; Bigwarfe T; Li H; Waltz E; Ahlberg J; Giragossian C; Roberts S
MAbs; 2016; 8(8):1606-1611. PubMed ID: 27598372
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Analysis of Human Neonatal Fc Receptor (FcRn) Tissue Expression in Transgenic Mice by Online Peptide Immuno-Affinity LC-HRMS.
Fan YY; Neubert H
Anal Chem; 2016 Apr; 88(8):4239-47. PubMed ID: 27012525
[TBL] [Abstract][Full Text] [Related]
8. Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics.
Avery LB; Wade J; Wang M; Tam A; King A; Piche-Nicholas N; Kavosi MS; Penn S; Cirelli D; Kurz JC; Zhang M; Cunningham O; Jones R; Fennell BJ; McDonnell B; Sakorafas P; Apgar J; Finlay WJ; Lin L; Bloom L; O'Hara DM
MAbs; 2018; 10(2):244-255. PubMed ID: 29271699
[TBL] [Abstract][Full Text] [Related]
9. Tissue expression profile of human neonatal Fc receptor (FcRn) in Tg32 transgenic mice.
Fan YY; Avery LB; Wang M; O'Hara DM; Leung S; Neubert H
MAbs; 2016 Jul; 8(5):848-53. PubMed ID: 27104806
[TBL] [Abstract][Full Text] [Related]
10. A Physiologically-Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data.
Jones HM; Zhang Z; Jasper P; Luo H; Avery LB; King LE; Neubert H; Barton HA; Betts AM; Webster R
CPT Pharmacometrics Syst Pharmacol; 2019 Oct; 8(10):738-747. PubMed ID: 31464379
[TBL] [Abstract][Full Text] [Related]
11. Application of human FcRn transgenic mice as a pharmacokinetic screening tool of monoclonal antibody.
Haraya K; Tachibana T; Nanami M; Ishigai M
Xenobiotica; 2014 Dec; 44(12):1127-34. PubMed ID: 25030041
[TBL] [Abstract][Full Text] [Related]
12. A Physiologically-Based Pharmacokinetic Model for the Prediction of "Half-Life Extension" and "Catch and Release" Monoclonal Antibody Pharmacokinetics.
Jones HM; Tolsma J; Zhang Z; Jasper P; Luo H; Weber GL; Wright K; Bard J; Bell R; Messing D; Kelleher K; Piche-Nicholas N; Webster R
CPT Pharmacometrics Syst Pharmacol; 2020 Sep; 9(9):534-541. PubMed ID: 32697437
[TBL] [Abstract][Full Text] [Related]
13. Combination of cassette-dosing and microsampling for reduced animal usage for antibody pharmacokinetics in cynomolgus monkeys, wild-type mice, and human FcRn transgenic mice.
Nagayasu M; Ozeki K
Pharm Res; 2021 Apr; 38(4):583-592. PubMed ID: 33782838
[TBL] [Abstract][Full Text] [Related]
14. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.
Shah DK; Betts AM
J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):67-86. PubMed ID: 22143261
[TBL] [Abstract][Full Text] [Related]
15. A precisely humanized FCRN transgenic mouse for preclinical pharmacokinetics studies.
Conner CM; van Fossan D; Read K; Cowley DO; Alvarez O; Xu SX; Webb DR; Jarnagin K
Biochem Pharmacol; 2023 Apr; 210():115470. PubMed ID: 36870576
[TBL] [Abstract][Full Text] [Related]
16. A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies.
Stracke J; Emrich T; Rueger P; Schlothauer T; Kling L; Knaupp A; Hertenberger H; Wolfert A; Spick C; Lau W; Drabner G; Reiff U; Koll H; Papadimitriou A
MAbs; 2014; 6(5):1229-42. PubMed ID: 25517308
[TBL] [Abstract][Full Text] [Related]
17. Human FcRn Transgenic Mice for Pharmacokinetic Evaluation of Therapeutic Antibodies.
Roopenian DC; Christianson GJ; Proetzel G; Sproule TJ
Methods Mol Biol; 2016; 1438():103-14. PubMed ID: 27150086
[TBL] [Abstract][Full Text] [Related]
18. Modeling approach to investigate the effect of neonatal Fc receptor binding affinity and anti-therapeutic antibody on the pharmacokinetic of humanized monoclonal anti-tumor necrosis factor-α IgG antibody in cynomolgus monkey.
Ng CM; Loyet KM; Iyer S; Fielder PJ; Deng R
Eur J Pharm Sci; 2014 Jan; 51():51-8. PubMed ID: 23999033
[TBL] [Abstract][Full Text] [Related]
19. Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice.
Kliwinski C; Cooper PR; Perkinson R; Mabus JR; Tam SH; Wilkinson TM; Giles-Komar J; Scallon B; Powers GD; Hornby PJ
Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G262-70. PubMed ID: 23220220
[TBL] [Abstract][Full Text] [Related]
20. Humanized FcRn mouse models for evaluating pharmacokinetics of human IgG antibodies.
Proetzel G; Roopenian DC
Methods; 2014 Jan; 65(1):148-53. PubMed ID: 23867339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
